MS vision loss mystery: is it scarring or cell death?
NCT ID NCT02543788
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study looked at 39 people with multiple sclerosis who have chronic vision problems. Researchers used eye exams, scans, and electrical tests to see if the vision loss is caused by nerve scarring (demyelination) or nerve cell death (degeneration). The goal is to better understand the root cause so doctors can predict and manage vision decline more effectively.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict and manage vision problems in MS patients by identifying the underlying cause.
- What could go wrong
- This is a small observational study with only 39 participants, so results may not apply to all MS patients. It aims to understand the disease, not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
39 people
The number who actually took part.
- Started
-
Sep 2014
- Finished
-
Aug 2016
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Inclusion criteria for patients * All patients may have a clinically definite, laboratory-supported diagnosis of multiple sclerosis according to the Mac Donald criteria (2010). * All patients may present a chronic visual complaint. * All patients may present mild to moderate chronic optic neuropathy (cf infra) * All patients may not have recent acute optic neuritis (\<2 years) * All patients will be informed about the design and purpose of the study, and all will give their informed, written consent to the protocol, which may have been approved by the local ethics committee. * Age: \> 18 * Able to understand the instructions * Having a health coverage * Able to sit down for 1 hour Diagnosis of mild to moderate chronic optic neuropathy For the diagnosis of optic neuropathy, patients will have to meet 3 of the 6 next criteria: 1. Far Visual Acuity (ETDRS charts, 100% contrast) \< 85 letters 2. Far Visual Acuity (ETDRS charts, 2.5% contrast) \< 60 letters 3. Mean visual field defect on static perimetry\> 2dB 4. Mean pRNFL in OCT \< 80 µ. 5. Color vision score \> 35 6. Disc pallor Diagnosis of mild to moderate optic neuropathy * Far Visual Acuity (ETDRS charts, 100% contrast) \>70 letters Diagnosis of chronic optic neuropathy * Stable or worsening of visual acuity, visual field and/or RNFL in OCT, at 6 month of interval \- Inclusion criteria for controls * Age \> 18 years * Visual acuity score (ETDRS) \> 85 * Able to understand the instructions * Having a health coverage * Informed and consenting to give his written consent Exclusion Criteria: * Non inclusion criteria for patients. * Ophthalmological * Other ophthalmological disorder that could impair corrected visual acuity (Maculopathy, Retinopathy…) * Ocular instability in primary position of gaze * Neurological * Ongoing seizure * Severe handicap that does not allow sitting down position for 1 hour * General * Unstable medical state * Severe renal insufficiency * Allergy to gadolinium * Claustrophobia * Implanted electrical stimulator (pace maker) * Metallic prosthesis or orthesis, cochlear implants * Intraocular foreign material * Pregnancy (on questioning) * Tutelage or any legal protection measure * Non inclusion criteria for controls * Any ophthalmological disorder that could impair corrected visual acuity * Any neurological disorder * MRI contraindication * Allergy to gadolinium * Severe renal insufficiency * Claustrophobia * Implanted electrical stimulator (pace maker) * Metallic prosthesis or orthesis, cochlear implants * Intraocular foreign material * Pregnancy (on questioning) * Tutelage or any legal protection measure
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic optic neuropathy in multiple sclerosis are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Unité de Neuro-Ophtalmologie - Hôpital Neurologique - HOSPICES CIVILS DE LYON
France, BRON, 69677, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can exercise rebuild muscle and balance in MS?
- Can diet ease the crushing fatigue of multiple sclerosis?
- One-Time CAR-T infusion tested against progressive MS
- Can PET scans reveal hidden brain inflammation in MS?
- Can a pill rebuild the Brain's insulation? MS trial puts remyelination to the test
- Migraines and tension headaches may be hidden companions to multiple sclerosis